Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Investing Activities (2024 - 2025)

BioScience Health Innovations has reported Cash from Investing Activities over the past 2 years, most recently at -$10786.0 for Q4 2025.

  • Quarterly Cash from Investing Activities rose 43.23% to -$10786.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26850.0 through Mar 2026, up 52.09% year-over-year, with the annual reading at -$56850.0 for FY2025, 118.34% down from the prior year.
  • Cash from Investing Activities was -$10786.0 for Q4 2025 at BioScience Health Innovations, up from -$16064.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$7037.0 in Q3 2024 and troughed at -$30000.0 in Q1 2025.